Know Cancer

or
forgot password

Association of NFKB1 -94 Polymorphism With Lung and/or Kidney Injury After Cardiac Surgery With Cardiopulmonary Bypass


N/A
18 Years
N/A
Not Enrolling
Both
Single Nucleotide Polymorphism, Acute Lung Injury, Kidney Injury

Thank you

Trial Information

Association of NFKB1 -94 Polymorphism With Lung and/or Kidney Injury After Cardiac Surgery With Cardiopulmonary Bypass


Inclusion Criteria:



- Chinese Han unrelated population

- undergoing elective cardiac surgery with CPB

Exclusion Criteria:

- malignant tumor

- autoimmune disease, immunodeficiency or immunosuppressive therapy

- chronic renal disease (glomerular filtration rate < 60ml/(min•1.73m2)) or liver
dysfunction (Child Pugh classification>A)

- COPD, tuberculosis or other chronic pulmonary diseases

- anemia with hemoglobin lower than 90mmHg

- bleeding disorders

- postoperative pericardial tamponade requiring re-operation

- postoperative low cardiac output syndrome or acute pulmonary edema after left cardiac
failure.

Type of Study:

Observational

Study Design:

Observational Model: Case Control, Time Perspective: Prospective

Outcome Measure:

lung injury and/or kidney injury after cardiac surgery with cardiopulmonary bypass

Outcome Time Frame:

24h after cardiac surgery

Safety Issue:

Yes

Authority:

China: Ethics Committee

Study ID:

PCSP-NFKB1

NCT ID:

NCT00819871

Start Date:

May 2008

Completion Date:

December 2008

Related Keywords:

  • Single Nucleotide Polymorphism
  • Acute Lung Injury
  • Kidney Injury
  • Acute Lung Injury
  • Respiratory Distress Syndrome, Adult
  • Lung Injury

Name

Location